Listen To The Experts

Elmar Nimmesgern has been in charge of different aspects of health research at the European Commission since 2000. He has been Deputy Head of Unit since 2013, initially in the strategy unit of the Health Directorate and since 2014 in the Innovative and Personalised Medicine unit. Before joining the European Commission, he worked for 5 years at Vertex Pharmaceuticals in Cambridge (USA), first as research scientist in the department of biophysical chemistry, then from 1997 to 2000 as project head of preclinical programme for IMPDH research. Elmar Nimmesgern is a biochemist by training; he performed cell biology research at the University of Munich and at Memorial-Sloan-Kettering Cancer Center in New York.